Treatment of Patients with Paget's Disease of Bone

ISSN： 0012-6667

Source： Drugs, Vol.58, Iss.5, 1999-11, pp. : 823-830

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Zoledronic acid for treatment of Paget's disease of bone

By Devogelaer Jean-Pierre Manicourt Daniel H

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 16, 2007-11 ,pp. : 2863-2869

Informa Healthcare

Access to resources Recommend Favorite

Zoledronic Acid: A Review of its Use in the Treatment of Paget's Disease of Bone

By Keating Gillian M. Scott Lesley J.

Drugs, Vol. 67, Iss. 5, 2007-01 ,pp. : 793-804

Adis International

Access to resources Recommend Favorite

Tiludronate. A new treatment for an old ailment: Paget’s disease of bone

By Morales-Piga A.

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 1, 1999-11 ,pp. : 157-170

Informa Healthcare

Access to resources Recommend Favorite

Prognostic Indicators in 35 Patients with Extramammary Paget's Disease

By Ito Yasuhiro Igawa Satomi Ohishi Yasushi Uehara Jiro Yamamoto Akemi I. Iizuka Hajime

Dermatologic Surgery, Vol. 38, Iss. 12, 2012-12 ,pp. : 1938-1944

Elsevier

Access to resources Recommend Favorite

Zoledronic acid: a guide to its use in Paget's disease of bone

By Adis International Limited

Drugs & Therapy Perspectives, Vol. 23, Iss. 10, 2007-10 ,pp. : 1-4

Adis International

Access to resources Recommend Favorite